We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Viraleze

News List

Latest testing confirms Viraleze highly effective against Alpha, Beta and Gamma COVID variants prnasia
June 18, 2021
New data released today shows that Australia's Viraleze™ anti-COVID nasal spray is more than 99.9% effective against three of the four deadliest variants of the SARS-CoV-2 virus.
Viraleze registered for sale in Covid-ravaged India prnasia
June 11, 2021
India's vast population will have access from today to the Australian developed anti-COVID nasal spray Viraleze™ following its registration in the country.
Scripps Research Institute testing shows Viraleze highly active against UK COVID strain prnasia
June 02, 2021
Australia's Viraleze anti-COVID nasal spray is active against the highly infectious UK variant of SARS-CoV-2, the virus that causes COVID-19, reducing infectivity of the virus by >98%, it was announced today in a major development for the product.